Insider Trading › EW › Insiders
Edwards Lifesciences Corp
EW·NYSE·
United States·Insider activity
United States·Insider activity$85.78
-0.70 (-0.81%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
EW
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EWS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, EW insiders filed 0 purchases ($0) and 25 sales ($11.4M) on the open market, by 7 insiders. Newest filing Sep 11, 2026 (27 days ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by EW insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$11.4MSales · 180 days
2,694Open-market transactions on record
7Insiders filing · 180 days
Purchases (code P) and sales (code S) of EW common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
2,694 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Lippis Daniel J.CVP, TAVR | Sale | −619 | $87.51 | $54K | 40.0Kdirect | Sep 11, 2026 | Sep 11, 2026 | Form 4 ↗ |
| Dahl Andrew M.SVP, Corporate Controller | Sale | −544 | $91.06 | $50K | 14.9Kdirect | Aug 31, 2026 | Aug 31, 2026 | Form 4 ↗ |
| Bruls AnnetteCVP, EMEACLA | Sale | −2,644 | $89.98 | $238K | 18.0Kdirect | Aug 28, 2026 | Aug 28, 2026 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT, Surgical & IHFM | Sale | −30.6K | $90.99 | $2.8M | 44.3Kdirect | Aug 26, 2026 | Aug 26, 2026 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT, Surgical & IHFM | Sale | −1,154 | $91.76 | $106K | 75.0Kdirect | Aug 26, 2026 | Aug 26, 2026 | Form 4 ↗ |
| Markowitz WayneCVP, JAPAC | Sale | −1,240 | $91.47 | $113K | 20.3Kdirect | Aug 26, 2026 | Aug 26, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −619 | $92.03 | $57K | 40.0Kdirect | Aug 11, 2026 | Aug 11, 2026 | Form 4 ↗ |
| Markowitz WayneCVP, JAPAC | Sale | −146 | $86.03 | $13K | 21.5Kdirect | Jul 30, 2026 | Jul 30, 2026 | Form 4 ↗ |
| Markowitz WayneCVP, JAPAC | Sale | −9,628 | $85.06 | $819K | 21.7Kdirect | Jul 28, 2026 | Jul 28, 2026 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −2,921 | $83.93 | $245K | 8,916indirect | Jul 27, 2026 | Jul 27, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −619 | $91.70 | $57K | 40.0Kdirect | Jul 10, 2026 | Jul 10, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −619 | $91.40 | $57K | 40.4Kdirect | Jun 30, 2026 | Jun 30, 2026 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −523 | $87.92 | $46K | 11.5Kindirect | Jun 17, 2026 | Jun 17, 2026 | Form 4 ↗ |
| Dahl Andrew M.SVP, Corporate Controller | Sale | −568 | $86.08 | $49K | 15.3Kdirect | May 29, 2026 | May 29, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −23.1K | $86.42 | $2.0M | 98.6Kindirect | May 27, 2026 | May 27, 2026 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT & Surgical | Sale | −1,500 | $84.60 | $127K | 44.3Kdirect | May 22, 2026 | May 22, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −620 | $81.14 | $50K | 40.4Kdirect | May 18, 2026 | May 18, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −8,000 | $81.82 | $655K | 31.0Kindirect | May 15, 2026 | May 18, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −9,968 | $82.07 | $818K | 22.8Kdirect | May 15, 2026 | May 18, 2026 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −35.5K | $77.92 | $2.8M | 12.0Kindirect | May 12, 2026 | May 12, 2026 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −845 | $78.40 | $66K | 47.5Kindirect | May 12, 2026 | May 12, 2026 | Form 4 ↗ |
| Markowitz WayneCVP, JAPAC | Sale | −593 | $79.73 | $47K | 21.7Kdirect | May 11, 2026 | May 11, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −1,019 | $83.98 | $86K | 33.7Kdirect | May 4, 2026 | May 4, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −1,000 | $82.99 | $83K | 33.9Kdirect | May 1, 2026 | May 4, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −19 | $83.99 | $2K | 34.9Kdirect | May 1, 2026 | May 4, 2026 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −8,324 | $79.79 | $664K | 39.7Kdirect | Apr 9, 2026 | Apr 9, 2026 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −4,676 | $80.50 | $376K | 48.0Kdirect | Apr 9, 2026 | Apr 9, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −1,019 | $80.98 | $83K | 33.9Kdirect | Apr 6, 2026 | Apr 6, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −18.0K | $80.05 | $1.4M | 21.3Kdirect | Apr 2, 2026 | Apr 2, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −4,676 | $80.59 | $377K | 39.3Kdirect | Apr 2, 2026 | Apr 2, 2026 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −7,901 | $85.21 | $673K | 39.7Kdirect | Mar 11, 2026 | Mar 11, 2026 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −5,099 | $84.46 | $431K | 47.6Kdirect | Mar 11, 2026 | Mar 11, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −1,019 | $85.38 | $87K | 33.9Kdirect | Mar 11, 2026 | Mar 11, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −11.3K | $85.93 | $974K | 21.3Kdirect | Mar 2, 2026 | Mar 2, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −24.0K | $83.84 | $2.0M | 21.3Kdirect | Feb 25, 2026 | Feb 26, 2026 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −19.9K | $76.61 | $1.5M | 83.9Kdirect | Feb 12, 2026 | Feb 13, 2026 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −2,532 | $77.13 | $195K | 103.8Kdirect | Feb 12, 2026 | Feb 13, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −1,019 | $85.70 | $87K | 22.0Kdirect | Jan 9, 2026 | Jan 9, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −8,708 | $85.98 | $749K | 31.9Kdirect | Jan 6, 2026 | Jan 6, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −2,632 | $84.62 | $223K | 40.6Kdirect | Jan 6, 2026 | Jan 6, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,900 | $83.74 | $494K | 39.0Kdirect | Dec 12, 2025 | Dec 12, 2025 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,486 | $83.79 | $460K | 44.9Kdirect | Dec 12, 2025 | Dec 12, 2025 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −1,019 | $84.03 | $86K | 22.0Kdirect | Dec 12, 2025 | Dec 12, 2025 | Form 4 ↗ |
| STONE HEISZ LESLIEDirector | Sale | −2,615 | $83.41 | $218K | 30.9Kdirect | Dec 12, 2025 | Dec 12, 2025 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT & Surgical | Sale | −2,000 | $84.38 | $169K | 32.2Kdirect | Dec 11, 2025 | Dec 11, 2025 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −11.3K | $83.83 | $951K | 50.4Kdirect | Dec 10, 2025 | Dec 10, 2025 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −3,863 | $83.45 | $322K | 8,597indirect | Dec 10, 2025 | Dec 10, 2025 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −7,700 | $84.47 | $650K | 39.9Kdirect | Dec 9, 2025 | Dec 9, 2025 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −21.5K | $85.21 | $1.8M | 84.8Kdirect | Dec 8, 2025 | Dec 10, 2025 | Form 4 ↗ |
| Markowitz WayneCVP, JAPAC | Sale | −583 | $86.01 | $50K | 17.6Kdirect | Dec 8, 2025 | Dec 8, 2025 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −10.0K | $83.02 | $832K | 39.9Kdirect | Nov 10, 2025 | Nov 10, 2025 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −2,974 | $83.30 | $248K | 49.9Kdirect | Nov 10, 2025 | Nov 10, 2025 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −1,020 | $82.55 | $84K | 22.0Kdirect | Nov 10, 2025 | Nov 10, 2025 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −2,500 | $81.95 | $205K | 31.0Kdirect | Aug 25, 2025 | Aug 25, 2025 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −8,950 | $78.06 | $699K | 206.9Kdirect | Aug 18, 2025 | Aug 18, 2025 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −4,114 | $79.46 | $327K | 22.0Kdirect | Jul 28, 2025 | Jul 28, 2025 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −8,950 | $75.23 | $673K | 206.9Kdirect | Jun 16, 2025 | Jun 16, 2025 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −967 | $77.32 | $75K | 8,597indirect | Jun 3, 2025 | Jun 3, 2025 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −2,570 | $77.40 | $199K | 50.4Kdirect | Jun 2, 2025 | Jun 2, 2025 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −16.1K | $77.21 | $1.2M | 9,564indirect | May 30, 2025 | Jun 3, 2025 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −1,500 | $75.08 | $113K | 33.5Kdirect | May 22, 2025 | May 22, 2025 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −330 | $74.42 | $25K | 26.6Kdirect | May 9, 2025 | May 9, 2025 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −11.3K | $74.40 | $837K | 41.1Kdirect | May 9, 2025 | May 9, 2025 | Form 4 ↗ |
| Markowitz WayneGM & SVP, Surgical | Sale | −268 | $75.08 | $20K | 9,299direct | May 7, 2025 | May 9, 2025 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −5,980 | $74.91 | $448K | 58.3Kdirect | May 5, 2025 | May 6, 2025 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −9,500 | $69.81 | $663K | 47.2Kdirect | Apr 14, 2025 | Apr 14, 2025 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −300 | $70.61 | $21K | 22.9Kdirect | Apr 8, 2025 | Apr 8, 2025 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −11.3K | $70.87 | $797K | 30.4Kdirect | Mar 26, 2025 | Mar 26, 2025 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −9,500 | $67.96 | $646K | 46.9Kdirect | Mar 13, 2025 | Mar 13, 2025 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −6,164 | $69.51 | $428K | 59.1Kdirect | Mar 10, 2025 | Mar 10, 2025 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −400 | $69.48 | $28K | 22.6Kdirect | Mar 10, 2025 | Mar 10, 2025 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −7,760 | $70.52 | $547K | 30.4Kdirect | Feb 28, 2025 | Feb 28, 2025 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −3,490 | $71.38 | $249K | 38.1Kdirect | Feb 28, 2025 | Feb 28, 2025 | Form 4 ↗ |
| LORANGER STEVEN RDirector | Sale | −5,739 | $76.42 | $439K | 60.4Kdirect | Feb 14, 2025 | Feb 14, 2025 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −11.3K | $75.76 | $852K | 30.6Kdirect | Feb 13, 2025 | Feb 13, 2025 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,400 | $75.74 | $485K | 46.9Kdirect | Feb 13, 2025 | Feb 13, 2025 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −100 | $76.26 | $8K | 53.3Kdirect | Feb 13, 2025 | Feb 13, 2025 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −500 | $76.34 | $38K | 23.2Kdirect | Feb 13, 2025 | Feb 13, 2025 | Form 4 ↗ |
| STONE HEISZ LESLIEDirector | Sale | −5,739 | $75.86 | $435K | 30.0Kdirect | Feb 13, 2025 | Feb 13, 2025 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −500 | $68.76 | $34K | 23.2Kdirect | Jan 16, 2025 | Jan 16, 2025 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,000 | $68.75 | $344K | 46.9Kdirect | Jan 16, 2025 | Jan 16, 2025 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −2,500 | $74.08 | $185K | 23.2Kdirect | Dec 16, 2024 | Dec 16, 2024 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −11.3K | $71.68 | $806K | 30.6Kdirect | Dec 9, 2024 | Dec 9, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,000 | $71.75 | $359K | 46.9Kdirect | Dec 9, 2024 | Dec 9, 2024 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −1,750 | $73.27 | $128K | 27.6Kdirect | Dec 6, 2024 | Dec 6, 2024 | Form 4 ↗ |
| Markowitz WayneGM & SVP, Surgical | Sale | −583 | $73.27 | $43K | 9,494direct | Dec 6, 2024 | Dec 6, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,000 | $65.57 | $328K | 46.9Kdirect | Nov 13, 2024 | Nov 13, 2024 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −25.0K | $65.91 | $1.6M | 198.5Kdirect | Nov 5, 2024 | Nov 5, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,000 | $69.51 | $348K | 46.9Kdirect | Oct 15, 2024 | Oct 15, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,000 | $66.77 | $334K | 46.9Kdirect | Sep 11, 2024 | Sep 11, 2024 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −1,250 | $69.95 | $87K | 29.3Kdirect | Aug 20, 2024 | Aug 20, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,000 | $66.08 | $330K | 46.9Kdirect | Aug 14, 2024 | Aug 14, 2024 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −500 | $94.18 | $47K | 23.2Kdirect | Jul 11, 2024 | Jul 11, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,000 | $93.29 | $466K | 46.9Kdirect | Jul 10, 2024 | Jul 10, 2024 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −535 | $90.00 | $48K | 23.5Kdirect | Jun 20, 2024 | Jun 20, 2024 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −5,225 | $87.47 | $457K | 30.6Kdirect | Jun 20, 2024 | Jun 20, 2024 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −400 | $88.11 | $35K | 35.8Kdirect | Jun 20, 2024 | Jun 20, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,000 | $87.54 | $438K | 46.9Kdirect | Jun 12, 2024 | Jun 12, 2024 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −8,617 | $87.68 | $756K | 68.2Kdirect | May 30, 2024 | May 30, 2024 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −5,625 | $90.45 | $509K | 30.6Kdirect | May 21, 2024 | May 21, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,000 | $87.81 | $439K | 47.7Kdirect | May 10, 2024 | May 13, 2024 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −857 | $85.60 | $73K | 23.9Kdirect | May 7, 2024 | May 9, 2024 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Purchase | +580 | $85.74 | $50K | 3,268indirect | May 6, 2024 | May 7, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −17.1K | $84.59 | $1.5M | 4,486direct | May 2, 2024 | May 2, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −12.2K | $85.02 | $1.0M | 21.6Kdirect | May 2, 2024 | May 2, 2024 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEACLA and JAPAC | Sale | −12.2K | $84.11 | $1.0M | 173.8Kdirect | May 1, 2024 | May 1, 2024 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEACLA and JAPAC | Sale | −2,160 | $84.83 | $183K | 186.1Kdirect | May 1, 2024 | May 1, 2024 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −6,550 | $85.74 | $562K | 19.1Kdirect | Apr 30, 2024 | Apr 30, 2024 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −700 | $86.40 | $60K | 25.6Kdirect | Apr 30, 2024 | Apr 30, 2024 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −857 | $92.34 | $79K | 17.5Kdirect | Apr 9, 2024 | Apr 9, 2024 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEACLA | Sale | −14.3K | $92.32 | $1.3M | 173.8Kdirect | Apr 8, 2024 | Apr 8, 2024 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEACLA | Sale | −107 | $92.65 | $10K | 188.1Kdirect | Apr 8, 2024 | Apr 8, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −12.4K | $92.33 | $1.1M | 39.8Kdirect | Apr 8, 2024 | Apr 8, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −100 | $92.66 | $9K | 52.2Kdirect | Apr 8, 2024 | Apr 8, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −16.6K | $92.70 | $1.5M | 4,486direct | Apr 4, 2024 | Apr 4, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −9,820 | $91.54 | $899K | 21.1Kdirect | Apr 4, 2024 | Apr 4, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −2,712 | $93.72 | $254K | 30.9Kdirect | Apr 4, 2024 | Apr 4, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −200 | $94.19 | $19K | 33.6Kdirect | Apr 4, 2024 | Apr 4, 2024 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −6,387 | $94.81 | $606K | 19.1Kdirect | Apr 1, 2024 | Apr 1, 2024 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −868 | $95.51 | $83K | 25.5Kdirect | Apr 1, 2024 | Apr 1, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −14.5K | $91.01 | $1.3M | 39.5Kdirect | Mar 13, 2024 | Mar 13, 2024 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEACLA and JAPAC | Sale | −14.4K | $91.68 | $1.3M | 173.6Kdirect | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Lippis Daniel J.CVP, JAPAC | Sale | −1,715 | $90.98 | $156K | 17.2Kdirect | Mar 7, 2024 | Mar 7, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −16.0K | $87.05 | $1.4M | 4,486direct | Mar 4, 2024 | Mar 4, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −13.3K | $86.21 | $1.1M | 20.5Kdirect | Mar 4, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −7,255 | $85.59 | $621K | 19.1Kdirect | Feb 29, 2024 | Feb 29, 2024 | Form 4 ↗ |
| GALLAHUE KIERANDirector | Sale | −3,058 | $87.61 | $268K | 67.2Kindirect | Feb 23, 2024 | Feb 26, 2024 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −7,000 | $86.75 | $607K | 22.8Kdirect | Feb 21, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −1,200 | $86.67 | $104K | 29.8Kdirect | Feb 21, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −27.0K | $85.62 | $2.3M | 34.8Kdirect | Feb 15, 2024 | Feb 15, 2024 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −20.0K | $86.46 | $1.7M | 34.8Kdirect | Feb 13, 2024 | Feb 15, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −10.5K | $85.81 | $904K | 39.5Kdirect | Feb 13, 2024 | Feb 13, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −470 | $86.35 | $41K | 50.0Kdirect | Feb 13, 2024 | Feb 13, 2024 | Form 4 ↗ |
| SELLERS ROBERT W.A.SVP, Corporate Controller | Sale | −12.2K | $87.00 | $1.1M | 13.1Kdirect | Feb 12, 2024 | Feb 12, 2024 | Form 4 ↗ |
| STONE HEISZ LESLIEDirector | Sale | −7,056 | $86.45 | $610K | 27.0Kdirect | Feb 8, 2024 | Feb 8, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −12.2K | $87.55 | $1.1M | 4,486direct | Feb 5, 2024 | Feb 5, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −9,761 | $86.44 | $844K | 16.7Kdirect | Feb 5, 2024 | Feb 5, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −6,422 | $88.63 | $569K | 26.4Kdirect | Feb 5, 2024 | Feb 5, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −1,000 | $89.61 | $90K | 32.8Kdirect | Feb 5, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −7,255 | $78.29 | $568K | 19.2Kdirect | Feb 1, 2024 | Feb 1, 2024 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −10.0K | $75.67 | $757K | 39.5Kdirect | Jan 12, 2024 | Jan 12, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −26.9K | $72.94 | $2.0M | 4,486direct | Jan 5, 2024 | Jan 5, 2024 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −2,500 | $73.46 | $184K | 31.3Kdirect | Jan 5, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −14.5K | $76.55 | $1.1M | 19.2Kdirect | Dec 29, 2023 | Dec 29, 2023 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −7,000 | $78.25 | $548K | 23.9Kdirect | Dec 15, 2023 | Dec 15, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −8,000 | $71.86 | $575K | 39.5Kdirect | Dec 13, 2023 | Dec 13, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −8,658 | $71.86 | $622K | 213.8Kdirect | Dec 13, 2023 | Dec 13, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −13.7K | $75.12 | $1.0M | 4,486direct | Dec 13, 2023 | Dec 13, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −10.6K | $74.22 | $787K | 18.2Kdirect | Dec 13, 2023 | Dec 13, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −3,200 | $73.15 | $234K | 28.8Kdirect | Dec 13, 2023 | Dec 13, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −1,828 | $75.73 | $138K | 32.0Kdirect | Dec 13, 2023 | Dec 13, 2023 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −3,500 | $70.00 | $245K | 23.9Kdirect | Dec 6, 2023 | Dec 6, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −5,402 | $65.64 | $355K | 213.8Kdirect | Nov 13, 2023 | Nov 13, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −3,158 | $64.68 | $204K | 219.2Kdirect | Nov 13, 2023 | Nov 13, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −100 | $66.21 | $7K | 222.4Kdirect | Nov 13, 2023 | Nov 13, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −3,700 | $65.66 | $243K | 39.5Kdirect | Nov 13, 2023 | Nov 13, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −2,300 | $64.72 | $149K | 43.2Kdirect | Nov 13, 2023 | Nov 13, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −29.4K | $67.18 | $2.0M | 4,486direct | Nov 3, 2023 | Nov 6, 2023 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −7,255 | $62.66 | $455K | 19.2Kdirect | Oct 31, 2023 | Oct 31, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −5,150 | $70.26 | $362K | 213.8Kdirect | Oct 13, 2023 | Oct 13, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −3,510 | $69.61 | $244K | 218.9Kdirect | Oct 13, 2023 | Oct 13, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −3,000 | $70.25 | $211K | 39.5Kdirect | Oct 13, 2023 | Oct 13, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −2,000 | $69.58 | $139K | 42.5Kdirect | Oct 13, 2023 | Oct 13, 2023 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −5,000 | $72.68 | $363K | 34.8Kdirect | Oct 10, 2023 | Oct 10, 2023 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −8,500 | $70.00 | $595K | 23.9Kdirect | Oct 3, 2023 | Oct 3, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −29.4K | $68.84 | $2.0M | 4,486direct | Oct 2, 2023 | Oct 2, 2023 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −7,255 | $69.54 | $505K | 19.2Kdirect | Sep 29, 2023 | Sep 29, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −4,500 | $73.71 | $332K | 39.5Kdirect | Sep 14, 2023 | Sep 14, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −8,660 | $73.63 | $638K | 213.8Kdirect | Sep 14, 2023 | Sep 14, 2023 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −5,000 | $76.00 | $380K | 34.8Kdirect | Sep 8, 2023 | Sep 8, 2023 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −8,500 | $76.07 | $647K | 23.9Kdirect | Sep 6, 2023 | Sep 6, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −29.4K | $75.86 | $2.2M | 4,486direct | Sep 5, 2023 | Sep 5, 2023 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −7,255 | $77.79 | $564K | 19.2Kdirect | Aug 31, 2023 | Aug 31, 2023 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −1,500 | $76.69 | $115K | 23.9Kdirect | Aug 29, 2023 | Aug 29, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −4,500 | $79.30 | $357K | 39.5Kdirect | Aug 14, 2023 | Aug 14, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −6,421 | $79.30 | $509K | 213.8Kdirect | Aug 14, 2023 | Aug 14, 2023 | Form 4 ↗ |
| STONE HEISZ LESLIEDirector | Sale | −3,303 | $78.87 | $261K | 27.0Kdirect | Aug 10, 2023 | Aug 10, 2023 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −5,000 | $78.64 | $393K | 34.8Kdirect | Aug 9, 2023 | Aug 9, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −29.1K | $79.86 | $2.3M | 54.3Kdirect | Aug 7, 2023 | Aug 7, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −300 | $80.54 | $24K | 83.3Kdirect | Aug 7, 2023 | Aug 7, 2023 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −7,255 | $84.35 | $612K | 19.2Kdirect | Jul 31, 2023 | Jul 31, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −3,500 | $92.94 | $325K | 39.5Kdirect | Jul 14, 2023 | Jul 14, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −8,660 | $92.94 | $805K | 213.8Kdirect | Jul 14, 2023 | Jul 14, 2023 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −5,000 | $90.52 | $453K | 34.8Kdirect | Jul 10, 2023 | Jul 10, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −21.7K | $90.63 | $2.0M | 54.3Kdirect | Jul 5, 2023 | Jul 5, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −7,622 | $91.22 | $695K | 76.0Kdirect | Jul 5, 2023 | Jul 5, 2023 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −7,255 | $93.27 | $677K | 19.2Kdirect | Jun 30, 2023 | Jun 30, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −3,500 | $89.77 | $314K | 39.5Kdirect | Jun 14, 2023 | Jun 14, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −5,810 | $89.87 | $522K | 213.8Kdirect | Jun 14, 2023 | Jun 14, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −2,850 | $90.71 | $259K | 219.6Kdirect | Jun 14, 2023 | Jun 14, 2023 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −5,000 | $85.81 | $429K | 35.1Kdirect | Jun 13, 2023 | Jun 13, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −18.7K | $84.57 | $1.6M | 86.2Kdirect | Jun 1, 2023 | Jun 1, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −5,396 | $85.08 | $459K | 104.9Kdirect | Jun 1, 2023 | Jun 1, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL ADirector | Sale | −5,300 | $83.43 | $442K | 110.3Kdirect | Jun 1, 2023 | Jun 1, 2023 | Form 4 ↗ |
| Wood Larry LGlobal President TAVR & Surg | Sale | −6,421 | $84.23 | $541K | 213.8Kdirect | May 24, 2023 | May 24, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −2,500 | $89.22 | $223K | 33.1Kdirect | May 10, 2023 | May 11, 2023 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −64.1K | $88.36 | $5.7M | 18.3Kdirect | May 10, 2023 | May 11, 2023 | Form 4 ↗ |
| Ullem Scott B.CVP, Chief Financial Officer | Sale | −16.6K | $89.22 | $1.5M | 82.4Kdirect | May 10, 2023 | May 11, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −13.9K | $88.29 | $1.2M | 81.7Kdirect | May 10, 2023 | May 11, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −5,984 | $88.94 | $532K | 105.1Kdirect | May 10, 2023 | May 11, 2023 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEACLA and JAPAC | Sale | −6,640 | $88.68 | $589K | 172.1Kdirect | May 9, 2023 | May 9, 2023 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −75.6K | $88.94 | $6.7M | 28.5Kdirect | May 9, 2023 | May 9, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,635 | $88.63 | $499K | 56.2Kdirect | May 5, 2023 | May 8, 2023 | Form 4 ↗ |
| SELLERS ROBERT W.A.SVP, Corporate Controller | Sale | −12.3K | $87.20 | $1.1M | 11.7Kdirect | Apr 28, 2023 | Apr 28, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −16.1K | $84.10 | $1.4M | 60.9Kdirect | Apr 14, 2023 | Apr 17, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −3,816 | $84.61 | $323K | 86.5Kdirect | Apr 14, 2023 | Apr 17, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,725 | $83.09 | $559K | 62.8Kdirect | Apr 6, 2023 | Apr 6, 2023 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEACLA and JAPAC | Sale | −6,640 | $83.10 | $552K | 169.1Kdirect | Apr 6, 2023 | Apr 6, 2023 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −4,435 | $77.47 | $344K | 18.9Kdirect | Mar 15, 2023 | Mar 15, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −10.7K | $77.86 | $833K | 60.9Kdirect | Mar 14, 2023 | Mar 14, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −9,175 | $77.32 | $709K | 81.1Kdirect | Mar 14, 2023 | Mar 14, 2023 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEACLA and JAPAC | Sale | −6,590 | $76.95 | $507K | 168.9Kdirect | Mar 8, 2023 | Mar 8, 2023 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEACLA and JAPAC | Sale | −50 | $77.43 | $4K | 175.5Kdirect | Mar 8, 2023 | Mar 8, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,725 | $76.96 | $518K | 62.6Kdirect | Mar 8, 2023 | Mar 8, 2023 | Form 4 ↗ |
| STONE HEISZ LESLIEDirector | Sale | −9,671 | $76.82 | $743K | 27.5Kdirect | Feb 16, 2023 | Feb 16, 2023 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −4,000 | $76.01 | $304K | 18.9Kdirect | Feb 15, 2023 | Feb 15, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −16.3K | $76.83 | $1.3M | 157.4Kdirect | Feb 14, 2023 | Feb 14, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −3,600 | $77.75 | $280K | 183.1Kdirect | Feb 14, 2023 | Feb 14, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,725 | $80.75 | $543K | 62.6Kdirect | Feb 6, 2023 | Feb 6, 2023 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT | Sale | −4,000 | $78.00 | $312K | 18.9Kdirect | Jan 17, 2023 | Jan 17, 2023 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −19.9K | $78.09 | $1.6M | 157.4Kdirect | Jan 13, 2023 | Jan 13, 2023 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,725 | $77.50 | $521K | 62.6Kdirect | Jan 9, 2023 | Jan 9, 2023 | Form 4 ↗ |
| Chopra DaveenCVP, Surgical Structural Heart | Sale | −4,000 | $74.80 | $299K | 18.9Kdirect | Dec 15, 2022 | Dec 15, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −12.2K | $76.04 | $924K | 157.4Kdirect | Dec 14, 2022 | Dec 14, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −7,420 | $76.93 | $571K | 179.0Kdirect | Dec 14, 2022 | Dec 14, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −300 | $77.51 | $23K | 186.4Kdirect | Dec 14, 2022 | Dec 14, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −6,936 | $76.96 | $534K | 202.2Kdirect | Dec 13, 2022 | Dec 13, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −300 | $77.48 | $23K | 209.2Kdirect | Dec 13, 2022 | Dec 13, 2022 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,725 | $74.32 | $500K | 62.6Kdirect | Dec 12, 2022 | Dec 12, 2022 | Form 4 ↗ |
| Chopra DaveenCVP, Surgical Structural Heart | Sale | −4,000 | $74.18 | $297K | 18.9Kdirect | Nov 15, 2022 | Nov 15, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −15.6K | $73.94 | $1.2M | 157.4Kdirect | Nov 14, 2022 | Nov 14, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −4,100 | $74.86 | $307K | 182.4Kdirect | Nov 14, 2022 | Nov 14, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −200 | $75.47 | $15K | 186.5Kdirect | Nov 14, 2022 | Nov 14, 2022 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,725 | $68.46 | $460K | 62.6Kdirect | Nov 8, 2022 | Nov 8, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −7,242 | $68.50 | $496K | 202.2Kdirect | Nov 8, 2022 | Nov 8, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −14.5K | $82.41 | $1.2M | 157.4Kdirect | Oct 14, 2022 | Oct 14, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −2,978 | $83.38 | $248K | 181.3Kdirect | Oct 14, 2022 | Oct 14, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −1,800 | $84.64 | $152K | 184.3Kdirect | Oct 14, 2022 | Oct 14, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −600 | $85.28 | $51K | 186.1Kdirect | Oct 14, 2022 | Oct 14, 2022 | Form 4 ↗ |
| Chopra DaveenCVP, Surgical Structural Heart | Sale | −4,000 | $84.77 | $339K | 18.9Kdirect | Oct 14, 2022 | Oct 14, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −7,242 | $82.12 | $595K | 202.2Kdirect | Oct 11, 2022 | Oct 11, 2022 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,725 | $85.00 | $572K | 62.6Kdirect | Oct 10, 2022 | Oct 11, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −16.7K | $84.07 | $1.4M | 157.4Kdirect | Sep 22, 2022 | Sep 22, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −3,100 | $84.66 | $262K | 183.5Kdirect | Sep 22, 2022 | Sep 22, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −100 | $85.26 | $9K | 186.6Kdirect | Sep 22, 2022 | Sep 22, 2022 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,725 | $90.94 | $612K | 62.6Kdirect | Sep 8, 2022 | Sep 8, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −7,242 | $89.00 | $645K | 202.2Kdirect | Sep 6, 2022 | Sep 6, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −15.8K | $104.92 | $1.7M | 157.4Kdirect | Aug 15, 2022 | Aug 15, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −4,002 | $104.03 | $416K | 182.6Kdirect | Aug 15, 2022 | Aug 15, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −100 | $105.41 | $11K | 186.6Kdirect | Aug 15, 2022 | Aug 15, 2022 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,725 | $105.01 | $706K | 62.6Kdirect | Aug 9, 2022 | Aug 9, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −5,324 | $104.59 | $557K | 202.2Kdirect | Aug 9, 2022 | Aug 9, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −1,918 | $105.03 | $201K | 207.6Kdirect | Aug 9, 2022 | Aug 9, 2022 | Form 4 ↗ |
| Zovighian Bernard JCVP, TMTT | Sale | −4,811 | $103.66 | $499K | 21.2Kdirect | Aug 5, 2022 | Aug 5, 2022 | Form 4 ↗ |
| Chopra DaveenCVP, Surgical Structural Heart | Sale | −1,000 | $102.49 | $102K | 18.9Kdirect | Aug 2, 2022 | Aug 2, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −7,951 | $96.87 | $770K | 166.9Kdirect | Jul 14, 2022 | Jul 14, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −6,000 | $94.56 | $567K | 174.8Kdirect | Jul 14, 2022 | Jul 14, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −5,924 | $95.89 | $568K | 180.8Kdirect | Jul 14, 2022 | Jul 14, 2022 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,725 | $97.60 | $656K | 62.6Kdirect | Jul 8, 2022 | Jul 8, 2022 | Form 4 ↗ |
| WANG HUIMINCVP, Japan & Intercontinental | Sale | −3,675 | $97.60 | $359K | 99.4Kdirect | Jul 8, 2022 | Jul 8, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −7,242 | $95.90 | $695K | 202.2Kdirect | Jul 5, 2022 | Jul 5, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −10.1K | $87.14 | $881K | 157.4Kdirect | Jun 14, 2022 | Jun 14, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −6,714 | $86.24 | $579K | 177.0Kdirect | Jun 14, 2022 | Jun 14, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −3,054 | $87.92 | $269K | 183.7Kdirect | Jun 14, 2022 | Jun 14, 2022 | Form 4 ↗ |
| WANG HUIMINCVP, Japan & Intercontinental | Sale | −3,675 | $87.75 | $322K | 99.3Kdirect | Jun 14, 2022 | Jun 14, 2022 | Form 4 ↗ |
| Zovighian Bernard JCVP, TMTT | Sale | −4,809 | $87.75 | $422K | 26.0Kdirect | Jun 14, 2022 | Jun 14, 2022 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −5,625 | $89.93 | $506K | 62.6Kdirect | Jun 13, 2022 | Jun 13, 2022 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −1,100 | $90.50 | $100K | 68.2Kdirect | Jun 13, 2022 | Jun 13, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −4,479 | $100.19 | $449K | 202.2Kdirect | Jun 1, 2022 | Jun 1, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −2,763 | $101.09 | $279K | 206.7Kdirect | Jun 1, 2022 | Jun 1, 2022 | Form 4 ↗ |
| Zovighian Bernard JCVP, TMTT | Sale | −9,000 | $100.83 | $907K | 30.8Kdirect | May 31, 2022 | May 31, 2022 | Form 4 ↗ |
| Chopra DaveenCVP, Surgical Structural Heart | Sale | −1,000 | $98.31 | $98K | 19.9Kdirect | May 26, 2022 | May 26, 2022 | Form 4 ↗ |
| Zovighian Bernard JCVP, TMTT | Sale | −4,809 | $95.52 | $459K | 39.8Kdirect | May 24, 2022 | May 24, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −13.1K | $94.54 | $1.2M | 157.4Kdirect | May 10, 2022 | May 10, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −12.0K | $95.39 | $1.1M | 183.0Kdirect | May 10, 2022 | May 10, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −4,700 | $93.41 | $439K | 195.0Kdirect | May 10, 2022 | May 10, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −2,724 | $96.12 | $262K | 199.7Kdirect | May 10, 2022 | May 10, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −4,568 | $96.38 | $440K | 206.1Kdirect | May 10, 2022 | May 10, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −2,674 | $95.71 | $256K | 210.6Kdirect | May 10, 2022 | May 10, 2022 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −6,725 | $98.71 | $664K | 64.3Kdirect | May 9, 2022 | May 10, 2022 | Form 4 ↗ |
| WANG HUIMINCVP, Japan & Intercontinental | Sale | −3,675 | $98.71 | $363K | 100.3Kdirect | May 9, 2022 | May 10, 2022 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer | Sale | −11.6K | $98.24 | $1.1M | 162.9Kdirect | May 9, 2022 | May 10, 2022 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −10.4K | $105.10 | $1.1M | 30.9Kdirect | May 4, 2022 | May 5, 2022 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −9,155 | $104.18 | $954K | 41.3Kdirect | May 4, 2022 | May 5, 2022 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −3,796 | $105.88 | $402K | 50.5Kdirect | May 4, 2022 | May 5, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −11.4K | $109.12 | $1.2M | 91.8Kdirect | Apr 29, 2022 | Apr 29, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −8,934 | $105.81 | $945K | 103.2Kdirect | Apr 29, 2022 | Apr 29, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −7,967 | $107.94 | $860K | 112.1Kdirect | Apr 29, 2022 | Apr 29, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −2,276 | $106.86 | $243K | 120.1Kdirect | Apr 29, 2022 | Apr 29, 2022 | Form 4 ↗ |
| MUSSALLEM MICHAEL AChairman & CEO · Director | Sale | −1,946 | $109.69 | $213K | 122.4Kdirect | Apr 29, 2022 | Apr 29, 2022 | Form 4 ↗ |
| Marsh Martha H.Director | Sale | −28.7K | $108.09 | $3.1M | 26.8Kdirect | Apr 28, 2022 | Apr 28, 2022 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −9,821 | $121.37 | $1.2M | 27.6Kdirect | Apr 11, 2022 | Apr 11, 2022 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −6,579 | $123.00 | $809K | 37.4Kdirect | Apr 11, 2022 | Apr 11, 2022 | Form 4 ↗ |
| Szyman Catherine M.CVP, Critical Care | Sale | −3,600 | $122.12 | $440K | 44.0Kdirect | Apr 11, 2022 | Apr 11, 2022 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer | Sale | −11.6K | $123.29 | $1.4M | 152.3Kdirect | Apr 8, 2022 | Apr 11, 2022 | Form 4 ↗ |
| Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer | Sale | −100 | $123.57 | $12K | 163.9Kdirect | Apr 8, 2022 | Apr 11, 2022 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −8,712 | $123.43 | $1.1M | 56.6Kdirect | Apr 8, 2022 | Apr 8, 2022 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −2,338 | $122.99 | $288K | 65.4Kdirect | Apr 8, 2022 | Apr 8, 2022 | Form 4 ↗ |
| WANG HUIMINCVP, Japan & Intercontinental | Sale | −3,675 | $123.07 | $452K | 98.2Kdirect | Apr 8, 2022 | Apr 8, 2022 | Form 4 ↗ |
| Wood Larry LCVP, TAVR | Sale | −3,867 | $121.52 | $470K | 197.6Kdirect | Apr 5, 2022 | Apr 5, 2022 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →